Nucleotide-binding area and leucine-rich repeat-containing (NLR) proteins perform as sensors that understand pathogen molecules and activate immunity. In vegetation, the buildup and activation of NLRs is regulated by SUPPRESSOR OF G2 ALLELE OF skp1 (SGT1). In this work, we discovered that an effector protein named RipAC, secreted by the plant pathogen Ralstonia solanacearum, associates with SGT1 to suppress NLR-mediated SGT1-dependent immune responses, together with these triggered by one other R. solanacearum effector, RipE1. RipAC doesn’t have an effect on the buildup of SGT1 or NLRs, or their interplay. However, RipAC inhibits the interplay between SGT1 and MAP kinases, and the phosphorylation of a MAPK goal motif within the C-terminal area of SGT1.
Such phosphorylation is enhanced upon activation of immune signaling and contributes to the activation of immune responses mediated by the NLR RPS2. Additionally, SGT1 phosphorylation contributes to resistance in opposition to R. solanacearum. Our outcomes shed gentle onto the mechanism of activation of NLR-mediated immunity, and counsel a optimistic suggestions loop between MAPK activation and SGT1-dependent NLR activation. Clathrin-mediated and caveolar endocytic pathways signify the key routes by way of which G protein-coupled receptors (GPCRs) could possibly be internalized.
GPCR kinase 2 (GRK2) and β-arrestins are consultant proteins that mediate the GPCR endocytosis. However, the molecular mechanisms by way of which GRK2 and β-arrestin mediate clathrin-mediated and caveolar endocytosis stay unclear. In this research, we decided the mobile parts and processes that mediate the selective interplay between clathrin/caveolin1 and GRK2/β-arrestins. For this we utilized the next: (i) mutant dopamine D2 receptor and β2 adrenoceptor during which the potential GRK2 phosphorylation websites have been altered and (ii) cells during which clathrin, caveolin1, β-arrestins, or Mdm2 expression have been knocked down.
Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus
The current research aimed to look at the consequences of FcγRIIB on systemic lupus erythematosus (SLE) and to examine the underlying mechanisms. For this function, lentiviral vector carrying the membrane‑certain sort FcγRIIB gene (mFcγRIIB lentivirus) and soluble FcγRIIB (sFcγRIIB) protein have been used to deal with B cells from sufferers with SLE. The B cells have been handled with calf thymus DNA (ctDNA) and anti‑calf thymus DNA‑immune complexes (anti‑ctDNA‑IC). mFcγRIIB lentivirus and sFcγRIIB protein have been additionally injected into MRL/lpr SLE mice.
The outcomes revealed that anti‑ctDNA‑IC therapy considerably downregulated the IgG antibody secretion of B cells handled with mFcγRIIB lentivirus. mFcγRIIB and sFcγRIIB decreased the phosphorylation stage of Bruton’s tyrosine kinase (BTK) in B cells, and elevated the phosphorylation stage of Lyn proto‑oncogene (Lyn), docking protein 1 (DOK1) and inositol polyphosphate‑5‑phosphatase D (SHIP). mFcγRIIB promoted the apoptosis of B cells. Following the therapy of MRL/lpr SLE mice with mFcγRIIB lentivirus, the degrees of urinary protein, serum anti‑nuclear and anti‑dsDNA antibodies have been decreased, whereas the degrees of mFcγRIIB in B cells have been elevated. mFcγRIIB ameliorated the pathologies of the kidneys, liver and lymph node tissues of the MRL/lpr SLE mice.
Following therapy of the MRL/lpr SLE mice with sFcγRIIB, the degrees of urinary protein, serum anti‑dsDNA antibody and BTK and SHIP phosphorylation ranges in B cells have been decreased, whereas the serum sFcγRIIB and sFcγRIIB‑IgG ranges have been elevated. On the entire, the findings of the current research show that recombinant FcγRIIB inhibits the secretion of IgG antibody by B cells from sufferers with SLE, ameliorates the signs of SLE in mice, and alters the phosphorylation ranges of downstream proteins of the FcγRIIB signaling pathway in B cells. These outcomes counsel that FcγRIIB might play preventive and therapeutic roles in SLE by inhibiting B cell activation by way of the FcγRIIB signaling pathway, which offers a novel principle and technique for the prevention and therapy of SLE.
Explicit illustration of protein exercise states considerably improves causal discovery of protein phosphorylation networks
Protein phosphorylation networks play an essential position in cell signaling. In these networks, phosphorylation of a protein kinase normally leads to its activation, which in flip will phosphorylate its downstream goal proteins. A phosphorylation community is actually a causal community, which might be discovered by causal inference algorithms. Prior efforts have utilized such algorithms to knowledge measuring protein phosphorylation ranges, assuming that the phosphorylation ranges signify protein exercise states. However, the phosphorylation standing of a kinase doesn’t at all times replicate its exercise state, as a result of interventions equivalent to inhibitors or mutations can instantly have an effect on its exercise state with out altering its phosphorylation standing.
Thus, when mobile techniques are subjected to intensive perturbations, the statistical relationships between phosphorylation states of proteins could also be disrupted, making it troublesome to reconstruct the true protein phosphorylation community. Here, we describe a novel framework to deal with this problem. We have developed a causal discovery framework that explicitly represents the exercise state of every protein kinase as an unmeasured variable and developed a novel algorithm referred to as “InferA” to infer the protein exercise states, which permits us to incorporate the protein phosphorylation stage, pharmacological interventions and prior information.
We utilized our framework to simulated datasets and to a real-world dataset. Our outcomes confirmed that clathrin-mediated endocytosis happens extra quickly than caveolar endocytosis. Clathrin-mediated endocytosis and the interplay between clathrin and GRK2/β-arrestin2 occurred in a GRK2-mediated receptor phosphorylation-dependent method. In distinction, caveolar endocytosis and the interplay between caveolin1 and GRK2/β-arrestin2 have been impartial of receptor phosphorylation standing.
 SCCA recombinant protein |
|||
| E62C01501 | EnoGene | 20ug | EUR 382 |
 SCCA1 recombinant protein |
|||
| E62C01502 | EnoGene | 20ug | EUR 382 |
 SCCA2 recombinant protein |
|||
| E62C01503 | EnoGene | 20ug | EUR 382 |
 P53 recombinant protein |
|||
| E62C02301 | EnoGene | 20ug | EUR 382 |
 DKK1 recombinant protein |
|||
| E62C02401 | EnoGene | 20ug | EUR 382 |
) PTPN1 Protein (Recombinant) |
|||
| 20-abx073070 | Abbexa |
|
|
) PPM1A Protein (Recombinant) |
|||
| 20-abx073071 | Abbexa |
|
|
) PTP4A3 Protein (Recombinant) |
|||
| 20-abx073078 | Abbexa |
|
|
) SKP1 Protein (Recombinant) |
|||
| 20-abx073140 | Abbexa |
|
|
) Ketohexokinase Protein (Recombinant) |
|||
| 20-abx073142 | Abbexa |
|
|
) NGAL Protein (Recombinant) |
|||
| 20-abx073150 | Abbexa |
|
|
) DDAH1 Protein (Recombinant) |
|||
| 20-abx073166 | Abbexa |
|
|
) PTP4A1 Protein (Recombinant) |
|||
| 20-abx073184 | Abbexa |
|
|
) PPP3R1 Protein (Recombinant) |
|||
| 20-abx073192 | Abbexa |
|
|
) PPM1F Protein (Recombinant) |
|||
| 20-abx073211 | Abbexa |
|
|
) PPME1 Protein (Recombinant) |
|||
| 20-abx073232 | Abbexa |
|
|
) PPP4C Protein (Recombinant) |
|||
| 20-abx073279 | Abbexa |
|
|
) ACAD8 Protein (Recombinant) |
|||
| 20-abx073280 | Abbexa |
|
|
) ACAT2 Protein (Recombinant) |
|||
| 20-abx073281 | Abbexa |
|
|
) RNASE3 Protein (Recombinant) |
|||
| 20-abx073373 | Abbexa |
|
|
) MAPKAPK3 Protein (Recombinant) |
|||
| 20-abx073468 | Abbexa |
|
|
) PRKAB2 Protein (Recombinant) |
|||
| 20-abx073469 | Abbexa |
|
|
) ATF3 Protein (Recombinant) |
|||
| 20-abx073484 | Abbexa |
|
|
) DYRK1A Protein (Recombinant) |
|||
| 20-abx073488 | Abbexa |
|
|
) PTPN6 Protein (Recombinant) |
|||
| 20-abx073509 | Abbexa |
|
|
NGAL Protein (Recombinant) |
|||
| 20-abx073513 | Abbexa |
|
|
NGAL Protein (Recombinant) |
|||
| 20-abx073525 | Abbexa |
|
|
) PTPMT1 Protein (Recombinant) |
|||
| 20-abx073545 | Abbexa |
|
|
) PPP1R14A Protein (Recombinant) |
|||
| 20-abx073553 | Abbexa |
|
|
) PPP1R2 Protein (Recombinant) |
|||
| 20-abx073582 | Abbexa |
|
|
) PRKA1RA Protein (Recombinant) |
|||
| 20-abx073603 | Abbexa |
|
|
) PPARG Protein (Recombinant) |
|||
| 20-abx073662 | Abbexa |
|
|
) PPP3R2 Protein (Recombinant) |
|||
| 20-abx073701 | Abbexa |
|
|
) ACADL Protein (Recombinant) |
|||
| 20-abx073728 | Abbexa |
|
|
) ACADVL Protein (Recombinant) |
|||
| 20-abx073752 | Abbexa |
|
|
) ACADS Protein (Recombinant) |
|||
| 20-abx073767 | Abbexa |
|
|
) ACADM Protein (Recombinant) |
|||
| 20-abx073777 | Abbexa |
|
|
) ACADSB Protein (Recombinant) |
|||
| 20-abx073808 | Abbexa |
|
|
) PPP1R8 Protein (Recombinant) |
|||
| 20-abx073809 | Abbexa |
|
|
) ATF4 Protein (Recombinant) |
|||
| 20-abx073858 | Abbexa |
|
|
) CDK2 Protein (Recombinant) |
|||
| 20-abx073859 | Abbexa |
|
|
) FGFR1 Protein (Recombinant) |
|||
| 20-abx073878 | Abbexa |
|
|
) Ribokinase Protein (Recombinant) |
|||
| 20-abx073896 | Abbexa |
|
|
) ADK Protein (Recombinant) |
|||
| 20-abx073897 | Abbexa |
|
|
) PTP4A2 Protein (Recombinant) |
|||
| 20-abx073900 | Abbexa |
|
|
) PTPN7 Protein (Recombinant) |
|||
| 20-abx073941 | Abbexa |
|
|
) PPP3CA Protein (Recombinant) |
|||
| 20-abx073950 | Abbexa |
|
|
) PPP1CA Protein (Recombinant) |
|||
| 20-abx073956 | Abbexa |
|
|
) ABHD14B Protein (Recombinant) |
|||
| 20-abx073961 | Abbexa |
|
|
) PPP1CC Protein (Recombinant) |
|||
| 20-abx073968 | Abbexa |
|
|
) PTPRC Protein (Recombinant) |
|||
| 20-abx073990 | Abbexa |
|
|
 Recombinant Protein G |
|||
| 7-05935 | CHI Scientific | 1mg | Ask for price |
Recombinant Protein G |
|||
| 7-05936 | CHI Scientific | 10mg | Ask for price |
Recombinant Protein G |
|||
| 7-05937 | CHI Scientific | 100mg | Ask for price |
 LIN7BHuman Recombinant Protein |
|||
| PROTQ9HAP6 | BosterBio | Regular: 10ug | EUR 317 |
|
Description: LIN7B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 230 amino acids (1-207 a.a.) and having a molecular mass of 25.3kDa.;LIN7B is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
 Recombinant SIV Protein |
|||
| VAng-Lsx0493-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Recombinant SIV p55- Strains: SIV mac 23g and SIV smH4 is glycosylated with N-linked sugars and produced using baculovirus vectors in insect cells. |
|||
 Recombinant Rotavirus Protein |
|||
| VAng-Lsx0471-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: RotaVirus, recombinant protein from MA 104 cells. |
|||
 Recombinant Echovirus Protein |
|||
| VAng-Lsx0595-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Echovirus, recombinant protein from E. coli. |
|||
 Recombinant Hantavirus Protein |
|||
| VAng-Lsx0152-100gEcoli | Creative Biolabs | 100 µg (E. coli) | EUR 670 |
|
Description: Hantavirus, recombinant protein from E. coli. |
|||
Recombinant Hantavirus Protein |
|||
| VAng-Lsx0152-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3402 |
|
Description: Hantavirus, recombinant protein from E. coli. |
|||
Recombinant Hantavirus Protein |
|||
| VAng-Lsx0152-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1787 |
|
Description: Hantavirus, recombinant protein from E. coli. |
|||
 Recombinant HDV Protein |
|||
| VAng-Lsx0220-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: HDV, recombinant protein from E. coli. |
|||
 Recombinant RSV Protein |
|||
| VAng-Lsx0448-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: RSV, recombinant protein from Hep-2 Cells. |
|||
 Recombinant Coxsackievirus Protein |
|||
| VAng-Lsx0074-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Coxsackievirus antigen, recombinant protein from E. coli. |
|||
 Recombinant EBV Protein |
|||
| VAng-Lsx0108-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: EBV, recombinant protein from human cells. |
|||
 Recombinant EBOV Protein |
|||
| VAng-Lsx0136-1mg | Creative Biolabs | 1 mg | EUR 1138 |
|
Description: EBOV, recombinant protein from E. coli. |
|||
 Recombinant HBV Protein |
|||
| VAng-Lsx0175-1mg | Creative Biolabs | 1 mg | EUR 3470 |
|
Description: HBV, recombinant protein from E. coli. |
|||
 Streptavidin Recombinant Protein |
|||
| PROTP22629-2 | BosterBio | Regular: 20mg | EUR 317 |
|
Description: Streptavidin Streptomyces Avidinii Recombinant produced in E.Coli. ;The molecular weight per tetramer is approximately 52kDa. |
|||
 Staphylokinase Recombinant Protein |
|||
| PROTP68802 | BosterBio | Regular: 100ug | EUR 317 |
|
Description: Staphylokinase Recombinant produced in E.Coli is a non-glycosylated polypeptide chain containing 136 amino acids and having a molecular weight of 16kDa.;The Staphylokinase is purified by proprietary chromatographic techniques. |
|||
 TIAL1Human Recombinant Protein |
|||
| PROTQ01085 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: TIAL1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 398 amino acids (1-375 a.a) and having a molecular mass of 44.0kDa.TIAL1 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
 (Recombinant- Tag)) TAGLN Recombinant Protein (Rat) (Recombinant- Tag) |
|||
| RP232205 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN2 Recombinant Protein (Rat) (Recombinant Tag) |
|||
| RP232208 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
| RP232211 | ABM | 100 ug | Ask for price |
TAGLN3 Recombinant Protein (Rat) (Recombinant Tag) |
|||
| RP232214 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) TAGAP Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP043930 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) CTAGE3P Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP053400 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE4 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP053403 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE8 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP053409 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE9 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP053412 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) STAG3L1 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030283 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) STAG3L2 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030286 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) STAG3L3 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030289 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) STAG3L4 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030292 | ABM | 100 ug | Ask for price |
TAGAP Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP030880 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) TAGLN Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP030883 | ABM | 100 ug | Ask for price |
TAGLN Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP030886 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN2 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030889 | ABM | 100 ug | Ask for price |
TAGLN2 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030892 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN3 Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP030895 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAG1A Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP038332 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAG1B Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP038335 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE5 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP038338 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE1 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP008266 | ABM | 100 ug | Ask for price |
CTAGE5 Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP008269 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) CTAGE6P Recombinant Protein (Human) (Recombinant Tag) |
|||
| RP008272 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGEP Recombinant Protein (Human) (Recombinant- Tag) |
|||
| RP008275 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
| RP126449 | ABM | 100 ug | Ask for price |
CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
| RP126452 | ABM | 100 ug | Ask for price |
CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
| RP126455 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) TAGAP Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
| RP177155 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) Tagap1 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
| RP177158 | ABM | 100 ug | Ask for price |
 (Recombinant- Tag)) TAGLN Recombinant Protein (Mouse) (Recombinant- Tag) |
|||
| RP177161 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN2 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
| RP177164 | ABM | 100 ug | Ask for price |
 (Recombinant Tag)) TAGLN3 Recombinant Protein (Mouse) (Recombinant Tag) |
|||
| RP177167 | ABM | 100 ug | Ask for price |
 Protein Export Protein SecB Recombinant Protein |
|||
| PROTP0AG86 | BosterBio | Regular: 25ug | EUR 317 |
|
Description: Recombinant E.Coli SecB produced in E.Coli is a single, non-glycosylated polypeptide chain containing 155 amino acids and having a molecular mass of 17.2 kDa. SecB was over-expressed in E. coli and purified by conventional chromatography. |
|||
 p53 Protein Human Recombinant Protein |
|||
| PROTP04637-1 | BosterBio | Regular: 5ug | EUR 479 |
|
Description: p53 Human Recombinant full length produced in E.Coli is a non-glycosylated, polypeptide chain having a total Mw of 81kDa. p53 Human Recombinant is fused to GST tag and purified by proprietary chromatographic techniques. |
|||
 Zika NS1 Protein Recombinant Protein |
|||
| PROTB5AHE9 | BosterBio | Regular: 0.5mg | EUR 788 |
|
Description: The E.Coli derived Recombinant Zika NS1 protein (Strain: ZikaSPH2015) having an Mw of 45kDa is derived from the full length Zika NS1 protein. ;The Zika NS1 protein is fused to a 6xHis tag at C-terminus and purified by proprietary chromatographic technique. |
|||
 Recombinant Protein Export Protein SecB |
|||
| 7-06340 | CHI Scientific | 5µg | Ask for price |
Recombinant Protein Export Protein SecB |
|||
| 7-06341 | CHI Scientific | 25µg | Ask for price |
Recombinant Protein Export Protein SecB |
|||
| 7-06342 | CHI Scientific | 1mg | Ask for price |
 PHF11 Protein Human Recombinant Protein |
|||
| PROTQ9UIL8 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: PHF11 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 351 amino acids (1-331 a.a.) and having a molecular mass of 39.7kDa.;PHF11 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
 BAD Protein Human Recombinant Protein |
|||
| PROTQ92934 | BosterBio | Regular: 5ug | EUR 479 |
|
Description: Bcl2 antagonist of cell death (BAD) Human Recombinant full length protein expressed in E.coli, shows a 51 kDa band on SDS-PAGE(Icluding GST tag). ;The BAD protein is purified by proprietary chromatographic techniques. |
|||
 (Recombinant-P Tag)) CTAG2 Recombinant Protein (Human) (Recombinant-P Tag) |
|||
| RP053376 | ABM | 100 ug | Ask for price |
 (Recombinant-P Tag)) CTAG2 Recombinant Protein (Rat) (Recombinant-P Tag) |
|||
| RP196619 | ABM | 100 ug | Ask for price |
 (Recombinant-P Tag)) CTAG2 Recombinant Protein (Mouse) (Recombinant-P Tag) |
|||
| RP126446 | ABM | 100 ug | Ask for price |
) Recombinant Protein S (PROS) |
|||
| 4-RPB971Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Protein S expressed in: E.coli |
|||
Recombinant Protein S (PROS) |
|||
| 4-RPB971Hu02 | Cloud-Clone |
|
|
|
Description: Recombinant Human Protein S expressed in: E.coli |
|||
Recombinant Protein S (PROS) |
|||
| 4-RPB971Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Protein S expressed in: E.coli |
|||
Recombinant Protein S (PROS) |
|||
| 4-RPB971Ra02 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Protein S expressed in: E.coli |
|||
) Recombinant Translocator Protein (TSPO) |
|||
| 4-RPJ628Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Translocator Protein expressed in: E.coli |
|||
Recombinant Translocator Protein (TSPO) |
|||
| 4-RPJ628Hu02 | Cloud-Clone |
|
|
|
Description: Recombinant Human Translocator Protein expressed in: E.coli |
|||
) Recombinant Envelope Protein (E) |
|||
| 4-RPX170Ge01 | Cloud-Clone |
|
|
|
Description: Recombinant Pan-species Envelope Protein expressed in: E.coli |
|||
) Recombinant Protein C (PROC) |
|||
| 4-RPA734Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Protein C expressed in: E.coli |
|||
Recombinant Protein C (PROC) |
|||
| 4-RPA734Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Protein C expressed in: E.coli |
|||
The simulation experiments demonstrated that express illustration of exercise states of protein kinases permits one to successfully signify the influence of interventions and thus enabled our framework to precisely recuperate the ground-truth causal community. Results from the real-world dataset confirmed that the express illustration of protein exercise states allowed an efficient and data-driven integration of the prior information by InferA, which additional leads to the restoration of a phosphorylation community that’s extra according to experiment outcomes.
A bacterial effector protein prevents MAPK-mediated phosphorylation of SGT1 to suppress plant immunity